Results 31 to 40 of about 321,693 (137)

Society of Family Planning clinical consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).

Contraception, 2022
Depot medroxyprogesterone acetate (DMPA) is a highly-effective, injectable contraceptive method that requires injections every 12-15 weeks. The need for return visits to a healthcare provider may present barriers to access, use, and continuation of DMPA.
J. Kohn, Elise D. Berlan, Jennifer H. Tang, A. Beasley   +3 more
semanticscholar   +3 more sources

Benefits, anxieties, acceptance, and barriers to the new injectable contraceptive DMPA-SC (Sayana Press): Clients’ perceptions in Sindh, Pakistan

Gates Open Research, 2023
Background: Injections are Pakistan's third most preferred contraceptive method because of their convenience. They represent a 2.5% share of the contraceptive prevalence rate (CPR) and contribute 10% to the current CPR.
Ghulam Yaseen Veesar, T. Lashari, Roshan Fida, M. A. Veesar   +3 more
semanticscholar   +2 more sources

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries. [PDF]

Glob Health Sci Pract, 2018
Nearly half a million doses of DMPA-SC were administered over 2 years in Burkina Faso, Niger, Senegal, and Uganda, with 29% of doses provided to first-time family planning users and 44% (in 3 countries) to adolescent girls and young women under age 25 ...
Stout A, Wood S, Barigye G, Kaboré A, Siddo D, Ndione I.   +5 more
europepmc   +2 more sources

Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial. [PDF]

Contraception, 2018
OBJECTIVE To describe women's experiences with subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to inform scale-up of self-administered DMPA-SC.
H. Burke, Mario Chen, Mercy Buluzi, Rachael Fuchs, S. Wevill, L. Venkatasubramanian, Leila Dal Santo, B. Ngwira   +7 more
semanticscholar   +3 more sources

Injectable contraceptive continuation and user experiences in Punjab, Pakistan: a non-randomized prospective cohort study protocol [PDF]

BMC Women's Health
Background Evidence from multiple pilots and post-introduction scale-up initiatives have demonstrated that self-administered subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) has potential to improve contraceptive continuation rates and expand ...
Hannah Tappis, Kanwal Qayyum, Emily Bryce, Aisha Fatima, Megan Christofield, Huma Haider, Afshan Ameen, Syed Muhammad Akbar Gardezi, Fazal Rafay, Fauzia Assad   +9 more
doaj   +2 more sources

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]

Glob Health Sci Pract, 2018
Over 1 year, the NGO-led project provided more than 14,000 units of DMPA-SC, mostly in community settings and to a substantial proportion (43%) of young women.
Odwe G, Gray K, Kyarimpa A, Obare F, Nagendi G.   +4 more
europepmc   +2 more sources

Quality of counseling for self-administering injectable contraception: field evidence from mystery client interactions in Lagos, Nigeria [PDF]

BMC Women's Health
Background Self-injection (SI) of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is a self-care intervention (drugs, diagnostics, or devices that can be provided mostly outside the health system) implemented across Nigeria.
Sneha Challa, Calvin Chiu, Ayobambo Jegede, Ivan Idiodi, Mikail Aliyu, Chioma Okoli, Shakede Dimowo, Aminat Tijani, Awawu Grace Nmadu, Rodio Diallo, Jenny Liu, Elizabeth Omoluabi   +11 more
doaj   +2 more sources

Acceptability and effectiveness of empathy-based provider training and community-level awareness activities on self-injectable contraceptive use in Niger, Lagos, and Oyo States, Nigeria: a mixed methods program evaluation [PDF]

BMC Women's Health
Background Interventions aimed to increase healthcare provider empathy and capacity to deliver person-centered care have been shown to improve healthcare seeking and outcomes.
Susan Ontiri, Claire W. Rothschild, Fauzia Tariq, Oluwaseun Adeleke, Michael Titus, Mopelola Raji, Julius Njogu, Susannah Gibbs, Robin Swearingen, Fidelis Edet   +9 more
doaj   +2 more sources

Accessing DMPA-SC through the public and private sectors in Nigeria: users’ characteristics and their experiences

Gates Open Research, 2018
Background: Beginning in 2015, subcutaneous depot medroxyprogesterone acetate (DMPA-SC) was added to the contraceptive method mix in Nigeria, primarily through social marketing in the private sector and community-based distribution in the public sector ...
Jenny X. Liu, Jennifer Shen, Eric Schatzkin, Olanike Adedeji, E. Kongnyuy, C. Onuoha, Morenike Fajemisin, K. Ayodeji, Elizabeth Omoluabi   +8 more
semanticscholar   +2 more sources

Behavioral Drivers Influencing Women’s Decision to Use Self-Injectable Contraception Provided by Community Health Surveillance Assistants in Rural Malawi [PDF]

Women's Health Reports
Introduction: Self-injection (SI) for contraceptive use is recommended for its proven ability to empower women and overcome barriers to contraceptive access. The World Health Organization endorsed SI as a self-care approach in 2019.
Martha Kamanga, Dilys Walker, Address Malata, Mandaachepa Nyando, Jessie Salamba, Alaizi Nkhoma, Innocencia Mtalimanja, Tamanda Jumbe, Emas Potolani, Alfred Maluwa, Chifundo Zimba, Josophine Changole, Rabecca Bika, Emily Himes, Lauren Suchman, Janelli Vallin, Beth Phillips, Jenny Liu, Kelsey Holt   +18 more
doaj   +2 more sources